Acute Effect of Topical Menthol on Carpal Tunnel Syndrome
NCT ID: NCT01716767
Last Updated: 2013-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2012-12-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Menthol
Biofreeze topical gel containing 3.5% menthol
Menthol
The gel will be applied at 2.5 ml per 500 cm2 to the hand, wrist and forearm
Placebo
Topical gel containing a menthol scent, but no active menthol
Placebo
The gel will be applied at 2.5 ml per 500 cm2 to the hand, wrist and forearm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Menthol
The gel will be applied at 2.5 ml per 500 cm2 to the hand, wrist and forearm
Placebo
The gel will be applied at 2.5 ml per 500 cm2 to the hand, wrist and forearm
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* positive Tinel test
* nocturnal hand/wrist pain
* pain intensity of at least 4 in the hand/wrist
* the pain should have lasted at least 3 months
Exclusion Criteria
* life-threatening disease
18 Years
67 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marquette University
OTHER
National Research Centre for the Working Environment, Denmark
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars L. Andersen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars L Andersen, PhD
Role: PRINCIPAL_INVESTIGATOR
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Research Centre for the Working Environment
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRMA07
Identifier Type: -
Identifier Source: org_study_id